Ampicillin Articles
Vietnam to resist drug price hike calls
2 June 2008
Positive Ph IIb data for Ipsat P1A
5 November 2007
FDA approves Abraxis' ANDA for generic combo antibiotic
4 December 2006
Nigeria's war on fake drugs shows progress
2 October 2006
19 additions to Italy's reimbursement list
20 February 2006
Vietnam's Mekophor exporting to Europe
3 March 2003
Russian drug prices in January
17 February 2003
Pfizer gets backing from Indian govt
26 November 2001
Tokyo stock comment; week to October 22
24 October 2001
Stock Commentary - Tokyo
18 October 2001
Japan pharma stock market - week to October 15
17 October 2001
Chinese pharma sales, other industry data
6 February 2001
Romania's Antibiotice hopes for US growth
18 September 2000
Galenika denies low quality claims
1 February 2000
Indian WTO moves on S Africa over dumping
12 May 1999
Brazil's EMS plans $30 million investment
16 April 1999
DSM's Acquisition Of Gist-Brocades Was "Good" Move
9 October 1998
Max-GB Establishes Penicillin Plant
1 October 1998
Vietnam: Arrests In Fake Drug Seizures
16 September 1998
EU To Hear Case Against Indian Exports
25 February 1998
Problems Revealed In Brazil Ampicillin Tests
31 December 1998
Chinese Sales of Joint-Venture Drugs Growing
26 September 1997
Indian Drug Prices Discussed In Parliament
12 August 1997
Glaxo Wellcome's Promising New Antibiotic
10 July 1997
Glaxo Wellcome's Promising New Antibiotic
8 July 1997
Russian Drug Output Fails To Meet Demand
27 January 1997
Eastern Europe/ Russia News Briefs
16 December 1996
Belmac: Bactosone Retard news
18 December 1995
India Claws Back "Unintended"Profits
12 June 1995
Disease ManagementThe Way Forward
15 May 1995
Synercid And Listeriosis
3 April 1995
$25 Bill Latin American Pharma Market In 2000
9 January 1995
Leciva 1994 Expectations
12 December 1994
BIOCRAFT APPROVAL
4 April 1994
NEW LOMEFLOXACIN EFFICACY DATA
19 April 1993
CHINESE FIRM SEEKS JOINT-VENTURE
5 April 1993
TEIKOKU ACQUIRES RIGHTS TO ARTES
15 February 1993
GIST-BROCADES IN INDIA JOINT VENTURE
8 February 1993
DYNAMICS OF THE US ANTIBIOTIC MARKET
22 June 1992
NIGERIAN PHARMA AD IMPROPRIETY SLAMMED
8 June 1992
COMPANY NEWS FROM CHINA
6 April 1992
COMPANY NEWS FROM CHINA
6 April 1992
Showing 1-44 of 44 articles
- 1
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
